Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Cancer and diabetes drugs expected to dominate 2025 Medicare negotiations under IRA
BioSpace
Wed, 09/25/24 - 12:08 pm
Tags:
Inflation Reduction Act, CMS, drug pricing, Pfizer, Merck, Bristol Myers Squibb, cancer, diabetes
Pfizer v Moderna COVID vaccine patents battle to go to appeal in UK
Reuters
Wed, 09/25/24 - 12:05 pm
Tags:
Pfizer, Moderna, legal, UK, vaccines, COVID-19
New migraine drugs less effective than previous generation of triptan meds: BMJ study
Fierce Pharma
Thu, 09/19/24 - 09:29 pm
Tags:
migraines, BMJ, Pfizer, Nurtec, AbbVie, Ubrelvy, Eli Lilly, Reyvow
ESMO: Pfizer sees weight gain in cancer patients, aims to enter phase 3 in 2025
Fierce Biotech
Tue, 09/17/24 - 09:57 am
Tags:
Pfizer, ESMO, cancer wasting, clinical trials, ponsegromab
Pfizer pushing BRAF lung cancer mutation testing to grow market for Braftovi
Reuters
Sun, 09/15/24 - 06:23 pm
Tags:
Pfizer, Baraftovi, BRAF inhibitor, non-small cell lung cancer
Weight-loss market to see 16 new drugs by 2029, report estimates
Reuters
Tue, 09/10/24 - 04:29 pm
Tags:
weight loss, obesity, Amgen, Pfizer, Roche, Novo Nordisk, Eli Lilly, Boehinger Ingelheim, Structure Therapeutics, Viking Therapeutics, Zealand Pharma, Altimmune
Bicycle Therapeutics' Lead Cancer Candidate's Has High-Opportunity
Benzinga
Mon, 09/9/24 - 10:49 am
Tags:
Bicycle Therapeutics, metastatic urothelial cancer, zele, Pfizer, Padcev
Pharma’s ‘it’ therapy — a new drug class gaining steam
Pharma Voice
Wed, 09/4/24 - 11:30 am
Tags:
protein degradation, Arvinas, Merck KGaA, Sanofi, Pfizer, Novartis
Valneva and Pfizer report positive data from trial of Lyme disease vaccine booster
Clinical Trials Arena
Tue, 09/3/24 - 11:25 am
Tags:
Valneva, Pfizer, VLA15, clinical trials, vaccines, Lyme disease
After obesity, Pfizer and Flagship pick 2 more targets for multibillion-dollar partnership
Fierce Biotech
Wed, 08/28/24 - 11:33 am
Tags:
Pfizer, Flagship Pioneering, Quotient, ProFound Therapeutics
Pfizer launches new website for migraine, respiratory offerings
Reuters
Tue, 08/27/24 - 10:57 am
Tags:
Pfizer, migraines, Respiratory, website
Ozempic on Wall Street's list for 2027 Medicare drug negotiations
Reuters
Fri, 08/23/24 - 10:59 am
Tags:
Ozempic, Novo Nordisk, Pfizer, GSK, Medicare, drug pricing
Updated COVID shots from Pfizer, Moderna cleared by FDA
BioPharma Dive
Thu, 08/22/24 - 10:03 pm
Tags:
COVID-19, vaccines, Pfizer, Moderna Therapeutics, FDA
Ambrosia lands $16m to ‘improve on existing GLP-1 drugs’
Longevity Technology
Wed, 08/21/24 - 11:26 am
Tags:
Ambrosia Biosciences, funding, GLP-1 agonists, obesity, Pfizer, Array Biopharma
Pfizer, BioNTech's combo mRNA shot is latest to be defeated by influenza strain B
Fierce Biotech
Fri, 08/16/24 - 11:25 am
Tags:
Pfizer, BioNTech, vaccines, MRNA, Flu, COVID-19
US court rules for AstraZeneca, erasing Pfizer's $107.5M jury award in patent infringement case
Fierce Pharma
Thu, 08/15/24 - 10:33 pm
Tags:
AstraZeneca, Pfizer, patents, Patent Infringement, legal, Tagrisso
Pfizer appoints AI chief, expanding digital leadership team
BioPharma Dive
Wed, 08/14/24 - 11:07 am
Tags:
Pfizer, artificial intelligence, digital pharma
Pfizer, looking to expand RSV vaccine's reach, touts its benefits in immunocompromised adults
Fierce Pharma
Mon, 08/12/24 - 11:42 am
Tags:
Pfizer, RSV, vaccines, Abrysvo, immunocompromised patients
Market share shakeup: Big Pharma’s bestselling drugs drive industry shifts in 2024’s first half
Pharma Voice
Thu, 08/8/24 - 11:07 am
Tags:
Big Pharma, JNJ, AbbVie, Pfizer, Roche, Eli Lilly, Novo Nordisk, Merck
Exelixis drops tissue factor-targeting ADC after deciding it's no match for Tivdak
Fierce Biotech
Wed, 08/7/24 - 11:19 am
Tags:
Exelixis, antibody-drug conjugate, tissue factor, XB002, Tivdak, Pfizer, Genmab

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.